tiprankstipranks
Sirius Real Estate (GB:SRE)
LSE:SRE

Sirius Real Estate (SRE) Income Statement

8 Followers

Sirius Real Estate Income Statement

Last quarter (Q2 2023), Sirius Real Estate's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, Sirius Real Estate's net income was €―. See Sirius Real Estate’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
-€ 210.18M€ 165.36M€ 150.01M€ 140.06M€ 123.65M
Cost of Revenue
-€ 87.69M€ 71.54M€ 64.67M€ 64.30M€ 60.58M
Gross Profit
-€ 122.49M€ 93.82M€ 85.34M€ 75.76M€ 63.07M
Operating Expense
-€ 36.55M€ 27.13M€ 21.28M€ 20.72M€ 22.67M
Operating Income
-€ 85.95M€ 66.69M€ 64.06M€ 55.04M€ 40.40M
Net Non Operating Interest Income Expense
-€ -20.23M€ 7.16M€ -11.33M€ -9.12M€ -8.03M
Other Income Expense
-€ -148.29M----
Pretax Income
-€ 168.93M€ 163.66M€ 110.77M€ 144.71M€ 89.65M
Tax Provision
-€ 20.93M€ 16.10M€ 12.62M€ 15.99M€ 8.29M
Earnings From Equity Interest Net Of Tax
-€ 6.94M----
Net Income Common Stockholders
-€ 147.87M€ 147.45M€ 98.14M€ 128.66M€ 81.27M
Basic EPS
-€ 0.13€ 0.14€ 0.10€ 0.13€ 0.09
Diluted EPS
-€ 0.13€ 0.14€ 0.09€ 0.13€ 0.09
Basic Average Shares
-€ 1.10B€ 1.04B€ 1.03B€ 1.01B€ 914.48M
Diluted Average Shares
-€ 1.11B€ 1.06B€ 1.04B€ 1.01B€ 939.39M
Dividend Per Share
-€ 0.04€ 0.04€ 0.03€ 0.03€ 0.03
Total Operating Income As Reported
------
Reported Normalized Basic E P S
---€ 0.05€ 0.05€ 0.04
Reported Normalized Diluted E P S
---€ 0.05€ 0.05€ 0.04
Rent Expense Supplemental
----€ 6.29M€ 6.08M
Total Expenses
-€ 124.23M€ -98.67M€ 85.95M€ 85.02M€ 83.25M
Net Income From Continuing And Discontinued Operation
-€ 147.87M€ 147.45M€ 98.14M€ 128.66M€ 81.27M
Normalized Income
-€ 182.44M€ 133.19M€ 98.11M€ 130.17M€ 84.61M
Interest Expense
---€ 10.92M€ 7.64M€ 7.89M
EBIT
-€ 192.15M€ 173.53M€ 121.69M€ 152.35M€ 97.54M
EBITDA
-€ 195.32M€ 173.53M€ 123.78M€ 153.73M€ 98.63M
Currency in EUR

Sirius Real Estate Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis